Tinidazole Export Market Intelligence: India's 315 Suppliers Shipping to 105 Countries — TransData Nexus 2026

Q: Who are the top tinidazole exporters from India?

The top tinidazole exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $2.2M (11.9% market share); 2. VANSH REMEDIES — $1.8M (9.6% market share); 3. CIPLA LIMITED — $1.6M (8.5% market share); 4. MICRO LABS LIMITED — $1.5M (8.3% market share); 5. CAPLIN POINT LABORATORIES LIMITED — $788.3K (4.3% market share). Together they account for 42.7% of India's total tinidazole export value.

Q: What is the total export value of tinidazole from India?

The total export value of tinidazole from India is $18.4M USD, recorded across 2,271 shipment transactions from 315 active exporters to 105 destination countries. The average shipment value is $8.1K.

Q: Which countries import tinidazole from India?

India exports tinidazole to 105 countries worldwide. The top importing countries are: TANZANIA (17.4% share, $3.2M), UGANDA (10.7% share, $2.0M), KENYA (8.3% share, $1.5M), NIGERIA (7.9% share, $1.5M), FRANCE (7.6% share, $1.4M). These five markets account for 51.9% of total export value.

Q: What is the HS code for tinidazole exports from India?

The primary HS code for tinidazole exports from India is 30049023. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of tinidazole exports from India?

The average unit price for tinidazole exports from India is $3.92 USD per unit, with prices ranging from $0.00 to $566.17 depending on formulation, packaging, and order volume. The total market is valued at $18.4M across 2,271 shipments.

Q: Which ports handle tinidazole exports from India?

The primary ports for tinidazole exports from India are DELHI AIR CARGO ACC (INDEL4) (13.2% of shipments), DELHI AIR (11.5% of shipments), SAHAR AIR (10.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.9% of shipments), NHAVA SHEVA SEA (INNSA1) (7.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of tinidazole?

India is one of the world's leading exporters of tinidazole due to its large base of 315 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports tinidazole to 105 countries, demonstrating 54% global market coverage.

Q: What certifications do Indian tinidazole exporters need?

Indian tinidazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import tinidazole from India?

There are 535 registered buyers importing tinidazole from India, spread across 105 countries. The repeat buyer rate is 51.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top tinidazole supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading tinidazole exporter from India with a market share of 11.9% and total export value of $2.2M across 23 shipments. The top 5 suppliers together control 42.7% of total export value.

Suresh Sormare

Tinidazole

India Pharmaceutical Trade Intelligence

$18.4M315 Suppliers105 CountriesHS 30049023

ExportsIndia → TANZANIA17.4%India → UGANDA10.7%

ImportsGERMANY → India$1.8K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: PHARMA ZEE

Tinidazole Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Tinidazole to the World

Between 2022 and 2026, India exported $18.4M worth of tinidazole across 2,271 verified shipments to 105 countries — covering 54% of world markets in the Advanced Antibiotics segment. The largest destination is TANZANIA (17.4%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 11.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Tinidazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Tinidazole export data snapshot — $18.4M · 315 exporters · 105 countriesTransData Nexus · Indian Customs Data

Top Tinidazole Exporters from India

315 active exporters · Ranked by export value

View all 315 →

Top Tinidazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.2M	23	6	11.9%
2	VANSH REMEDIES

Top Countries Importing Tinidazole from India

105 destination markets · Ranked by import value

All 105 countries →

Top Countries Importing Tinidazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	TANZANIA	$3.2M	17.4%
2	UGANDA	$2.0M	10.7%
3	KENYA	$1.5M	8.3%
4	NIGERIA	$1.5M	7.9%
5	FRANCE	$1.4M	7.6%
6	RUSSIA	$1.4M	7.6%
7	VIETNAM	$983.9K	5.4%
8	KAZAKHSTAN	$578.0K	3.1%
9	UKRAINE	$425.7K	2.3%
10	PAPUA NEW GUINEA	$406.9K	2.2%

TANZANIA is India's largest tinidazole export destination, absorbing 17.4% of total exports worth $3.2M. The top 5 importing countries — TANZANIA, UGANDA, KENYA, NIGERIA, FRANCE — together account for 51.9% of India's total tinidazole export value. The remaining 100 destination countries collectively receive the other 48.1%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Tinidazole to India?

1 origin countries · Total import value: $1.8K

India imports tinidazole from 1 countries with a combined import value of $1.8K. The largest supplier is GERMANY ($1.8K, 1 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Tinidazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$1.8K	1	100.0%

GERMANY is the largest supplier of tinidazole to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Tinidazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, tinidazole is approved for various indications, including trichomoniasis, giardiasis, and bacterial vaginosis. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for tinidazole tablets, with strengths of 250 mg and 500 mg. Notably, approvals were granted to manufacturers such as Chartwell RX on April 30, 2012, Edenbridge Pharmaceuticals on August 4, 2015, and Thinq Pharm-CRO Pvt on October 9, 2013. These approvals signify the availability of generic versions, enhancing market competition and accessibility.

The substantial number of ANDA approvals reflects a competitive market landscape, offering opportunities for Indian exporters. However, compliance with the FDA's stringent regulatory requirements, including Good Manufacturing Practices (GMP) and potential import alerts, is imperative. As of March 2026, there are no active FDA import alerts specifically targeting tinidazole products from India, indicating a favorable regulatory environment for exporters.

2EU & UK Regulatory Framework

In the European Union, tinidazole is subject to the European Medicines Agency's (EMA) centralized or decentralized marketing authorization procedures, depending on the applicant's strategy. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process within the United Kingdom. Both agencies mandate adherence to the European Union's Good Manufacturing Practice (EU GMP) guidelines, ensuring product quality and safety.

Indian exporters targeting these markets must obtain the necessary marketing authorizations and demonstrate compliance with EU GMP standards. This involves regular inspections and audits to verify manufacturing processes meet the required quality benchmarks. As of March 2026, there have been no significant regulatory actions or recalls concerning tinidazole in the EU or UK markets, suggesting stable market conditions for compliant exporters.

3WHO Essential Medicines & Global Standards

Tinidazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in addressing priority health needs globally. The 24th edition of the list, published in September 2025, continues to feature tinidazole, reflecting its recognized efficacy and safety profile. This inclusion facilitates its adoption in national essential medicines lists, particularly in low- and middle-income countries.

Regarding pharmacopoeial standards, tinidazole is monographed in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is crucial for ensuring product quality and acceptance in international markets.

4India Regulatory Classification

In India, tinidazole is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. This classification necessitates that tinidazole be dispensed only with a valid prescription from a registered medical practitioner. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines. As of March 2026, tinidazole is not listed under the DPCO's price control list, allowing manufacturers to set prices based on market dynamics.

For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. However, tinidazole is not currently subject to such export restrictions, streamlining the export process for Indian manufacturers.

5Patent & Exclusivity Status

Tinidazole's primary patents have expired, leading to the availability of multiple generic versions in various markets. This patent expiration has intensified generic competition, resulting in more affordable pricing and increased accessibility. Indian pharmaceutical companies have capitalized on this opportunity, becoming significant players in the global tinidazole market.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, reaffirming tinidazole's inclusion, which may influence procurement decisions in member countries.

In August 2025, the NPPA conducted a review of essential medicines pricing but did not include tinidazole under price control, allowing market-driven pricing to continue.

In October 2025, the EMA issued updated GMP guidelines, emphasizing stricter compliance measures, which Indian exporters must adhere to for market access.

In December 2025, the CDSCO introduced an expedited approval process for generic drugs, potentially benefiting tinidazole manufacturers seeking faster domestic market entry.

In February 2026, the FDA conducted inspections of Indian pharmaceutical facilities producing tinidazole, with no significant compliance issues reported, indicating robust manufacturing practices.

These developments underscore the dynamic regulatory environment affecting tinidazole's production and export. Indian manufacturers must remain vigilant and adaptable to maintain compliance and capitalize on emerging opportunities in the global pharmaceutical market.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Tinidazole

Retail & reference prices across 9 markets vs. India FOB export price of $3.92/unit

Global Price Benchmark for Tinidazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	The FDA Orange Book lists Tinidazole as an approved drug, but specific pricing information is not provided.
United Kingdom	Data not available	GBP	The NHS Drug Tariff includes Tinidazole; however, specific pricing details are not publicly disclosed.
Germany	Data not available	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates Tinidazole, but specific pricing information is not publicly available.
Australia

Supply Chain Risk Assessment — Tinidazole

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Tinidazole, an antiprotozoal and antibacterial agent, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, as reported by the U.S. Pharmacopeia in October 2025.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, military escalations in the Middle East led to the closure of the Strait of Hormuz, a critical passage for global trade. This disruption has significantly impacted the supply of raw materials, including those essential for pharmaceutical manufacturing, leading to production delays and increased costs.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Tinidazole account for 42.7% of the total export value, with SUN PHARMACEUTICAL INDUSTRIES LIMITED leading at 11.9%. This concentration poses a risk, as any operational disruptions within these key suppliers could significantly impact global supply chains.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic manufacturing of critical APIs and reduce reliance on imports. In October 2024, two greenfield plants were inaugurated under this scheme to produce essential molecules for antibiotics, marking a significant step towards self-sufficiency.

Access Complete Tinidazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,271 transactions across 105 markets.

Request Demo View Pricing

Frequently Asked Questions — Tinidazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top tinidazole exporters from India?

The leading tinidazole exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, VANSH REMEDIES, CIPLA LIMITED, and 12 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 11.9% market share ($2.2M). The top 5 suppliers together control 42.7% of total export value.

What is the total export value of tinidazole from India?

The total export value of tinidazole from India is $18.4M, recorded across 2,271 shipments from 315 active exporters to 105 countries. The average shipment value is $8.1K.

Which countries import tinidazole from India?

India exports tinidazole to 105 countries. The top importing countries are TANZANIA (17.4%), UGANDA (10.7%), KENYA (8.3%), NIGERIA (7.9%), FRANCE (7.6%), which together account for 51.9% of total export value.

What is the HS code for tinidazole exports from India?

The primary HS code for tinidazole exports from India is 30049023. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tinidazole

Tinidazole

Top Tinidazole Exporters from India

Top Countries Importing Tinidazole from India

Who Supplies Tinidazole to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Tinidazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Tinidazole

Supply Chain Risk Assessment — Tinidazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Tinidazole Trade Intelligence

Frequently Asked Questions — Tinidazole Exports from India

Who are the top tinidazole exporters from India?

What is the total export value of tinidazole from India?

Which countries import tinidazole from India?

What is the HS code for tinidazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of tinidazole exports from India?

Which ports handle tinidazole exports from India?

Why is India a leading exporter of tinidazole?

What certifications do Indian tinidazole exporters need?

How many buyers import tinidazole from India?

What is the market share of the top tinidazole exporter from India?

Analysis Methodology